l9n/ Connecticut

2023 Regular Session

Senate Bill 80

AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.

Did not become law. It stopped in the House of Representatives on May 5, 2023. The 2023 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To provide that the Commissioner of Consumer Protection shall adopt regulations to ensure that there is a sufficient supply of dulaglutide and semaglutide to treat patients in this state who have been diagnosed with type II diabetes.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

4 co-sponsors

Kevin C. Kelly, Tony Hwang, Saud Anwar, Patricia Billie Miller

In the House of Representatives

    1 co-sponsor

    Kathy Kennedy

    Its course

    January 12 to May 5, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

    Each committee stop sits inside its chamber.

    Every action16 actions on 12 days

    In the SenateJan 12 to May 4112 days

    General Law CommitteeJan 12 to Mar 249 days

    In the House of RepresentativesMay 4 to May 5 · stopped1 day

    Text

    Each version as the General Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the General Assembly published it is below.

    In the Senate Jan 12 – May 4

    1. Introduced and sent to General Law Committee
    2. Heard in General Law Committee
    3. Drafted as a bill by General Law Committee
    4. Sent to General Law Committee
    5. General Law Committee recommended it
    6. Passed the Senate

    In the House of Representatives May 5

    1. Arrived in the House of Representatives
    All 16 actions, as published